Skip to main content
Log in

Should we change our mind about second trimester biochemical aneuploidy screening markers of patients with polycystic ovary syndrome?

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Maliqueo M, Lara HE, Sánchez F, Echiburú B, Crisosto N, Sir-Petermann T (2013) Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 166(2):151–155

    Article  CAS  PubMed  Google Scholar 

  2. Segal S, Elmadjian M, Takeshige T, Karp S, Mercado R, Rivnay B (2010) Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance. Reprod Biomed Online 20(5):675–680

    Article  CAS  PubMed  Google Scholar 

  3. Karsli MF, Gultekin IB, Cakmak B, Yeral MI, Seckin KD, Alt Nboga O, Kucukozkan T (2014) Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome? Prenat Diagn 34(11):1073–1076

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

The manuscript does not require ethics standards.

Informed consent

The manuscript does not require informed consent.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Korkmaz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Korkmaz, V., Kurdoglu, Z. & Ergun, Y. Should we change our mind about second trimester biochemical aneuploidy screening markers of patients with polycystic ovary syndrome?. J Endocrinol Invest 38, 1383–1384 (2015). https://doi.org/10.1007/s40618-015-0329-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-015-0329-0

Keywords

Navigation